New study aims to make vital malaria drug safer for millions
Disease control
Recruiting now
This study is testing the safety and effectiveness of a malaria drug called primaquine in people who have a common enzyme deficiency called G6PD. It will enroll 100 adults with a specific type of malaria. The goal is to find safer dosing schedules so this important drug can be us…
Phase: PHASE4 • Sponsor: Menzies School of Health Research • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC